Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uterine re-curettage before methotrexate for post-molar gestational trophoblastic neoplasia
NL-OMON23724Active, not recruiting
- Sponsor
- HC van Doorn
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate, folinic acid and actinomycin D in trophoblastic tumour and gestational trophoblastic disease (GTD) (2 arms), sponsored by HC van Doorn. Primary endpoint: Number of chemotherapy courses to complete response. Started Dec 2011; status: active, not recruiting.
02
Drugs
methotrexatefolinic acidactinomycin D
03
Conditions
trophoblastic tumourgestational trophoblastic disease (GTD)
Beyond the preview
Go deeper on NL-OMON23724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23724.